327 results
CORRESP
MYGN
Myriad Genetics, Inc.
8 Mar 12
Correspondence with SEC
12:00am
benefits that you state was credited to additional paid in capital during the year ended June 30, 2011 to where that amount is included in your … established a valuation allowance in the same year in which it recognized the DTA associated with the excess tax benefits.
At its September 13, 2005
8-K
EX-10.1
MYGN
Myriad Genetics, Inc.
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
, or a failure by the Company to provide the compensation and benefits provided for in this Agreement; or (iii) a material breach by the Company … of such performance-based condition.
(iv) Benefits Payments. Upon completion of appropriate forms and subject to applicable terms and conditions under
8-K
EX-10.1
dnj6ex
2 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
qntmjcsz
12 May 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
l1bvih1bdng 0o14sav
9 Feb 22
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.3
c8bf98nakv5a afbyp
9 Oct 14
Entry into a Material Definitive Agreement
12:00am